Publications
160 results found
Croisier E, MRes DE, Deprez M, et al., 2006, Comparative study of commercially available anti-α-synuclein antibodies, NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol: 32, Pages: 351-356, ISSN: 0305-1846
- Author Web Link
- Cite
- Citations: 49
Fernando FS, Howell OW, Dexter DT, et al., 2006, Optimisation of the isolation and characterisation of mRNA from human post-mortem tissues for gene expression microarray studies, JOURNAL OF NEURAL TRANSMISSION, Vol: 113, Pages: II-III, ISSN: 0300-9564
Datla KP, Zbarsky V, Dexter DT, 2006, Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats, JOURNAL OF NEURAL TRANSMISSION, Vol: 113, Pages: 583-591, ISSN: 0300-9564
- Author Web Link
- Cite
- Citations: 13
Croisier E, Moran LB, Dexter DT, et al., 2006, Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition (vol 2, pg 14, 2005), JOURNAL OF NEUROINFLAMMATION, Vol: 3, ISSN: 1742-2094
Moran LB, Duke DC, Deprez M, et al., 2006, Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease, 107th Meeting of the British-Neuropathological-Society, Publisher: WILEY, Pages: 222-222, ISSN: 0305-1846
- Author Web Link
- Cite
- Citations: 1
Moran LB, Duke DC, Deprez M, et al., 2006, Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease, NEUROGENETICS, Vol: 7, Pages: 1-11, ISSN: 1364-6745
- Author Web Link
- Cite
- Citations: 177
Ward R, Cirkovic-Vellichovia T, Ledeque F, et al., 2006, Neuroprotection by taurine and taurine analogues, Pages: 299-306, ISSN: 0065-2598
- Cite
- Citations: 29
Ward R, Cirkovic-Vellichovia T, Ledeque F, et al., 2006, Neuroprotection by taurine and taurine analogues, 15th Taurine Meeting, Publisher: SPRINGER-VERLAG BERLIN, Pages: 299-306, ISSN: 0065-2598
- Author Web Link
- Cite
- Citations: 26
Luximon-Ramma A, Neergheen VS, Bahorun T, et al., 2006, Assessment of the polyphenolic composition of the organic extracts of Mauritian black teas: A potential contributor to their antioxidant functions, BIOFACTORS, Vol: 27, Pages: 79-91, ISSN: 0951-6433
- Author Web Link
- Cite
- Citations: 18
Zbarsky V, Datla KP, Parkar S, et al., 2005, Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease, FREE RADICAL RESEARCH, Vol: 39, Pages: 1119-1125, ISSN: 1071-5762
- Author Web Link
- Cite
- Citations: 347
Vernon AC, Palmer S, Datla KP, et al., 2005, Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease, EUROPEAN JOURNAL OF NEUROSCIENCE, Vol: 22, Pages: 1799-1806, ISSN: 0953-816X
- Author Web Link
- Cite
- Citations: 64
Duke DC, Moran LB, Croisier EM, et al., 2005, Correlation between mitochondrial respiratory chain and ubiquitin-proteasome gene expression in the human substantia nigra, 106th Annual Meeting of the British-Neuropathological-Society, Publisher: WILEY, Pages: 222-223, ISSN: 0305-1846
Croisier E, Elfant D, Pearce RKB, et al., 2005, Comparison of commercial anti-alpha synuclein antibodies and standardization of a protocol, 106th Annual Meeting of the British-Neuropathological-Society, Publisher: WILEY, Pages: 245-245, ISSN: 0305-1846
Luximon-Ramma A, Bahorun T, Crozier A, et al., 2005, Characterization of the antioxidant functions of flavonoids and proanthocyanidins in Mauritian black teas, FOOD RESEARCH INTERNATIONAL, Vol: 38, Pages: 357-367, ISSN: 0963-9969
- Author Web Link
- Cite
- Citations: 93
Croisier E, Moran LB, Dexter DT, et al., 2005, Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition, JOURNAL OF NEUROINFLAMMATION, Vol: 2, ISSN: 1742-2094
- Author Web Link
- Open Access Link
- Cite
- Citations: 280
Gillies GE, Murray HE, Dexter D, et al., 2004, Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease, PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, Vol: 78, Pages: 513-522, ISSN: 0091-3057
- Author Web Link
- Cite
- Citations: 96
Datla KP, Bennett RD, Zbarsky V, et al., 2004, The antioxidant drink "effective microorganism-X (EM-X)" pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease, JOURNAL OF PHARMACY AND PHARMACOLOGY, Vol: 56, Pages: 649-654, ISSN: 0022-3573
- Author Web Link
- Cite
- Citations: 25
Duke DC, Moran LB, Turkheimer FE, et al., 2004, Expression profiling of the parkinsonian substantia nigra using microarrays, 8th International Congress of Parkinsons Disease and Movement Disoders, Publisher: WILEY-LISS, Pages: S38-S39, ISSN: 0885-3185
Graeber MB, Dexter D, Pearce RKB, et al., 2003, Parkinson's disease: an update., Neuropathol Appl Neurobiol, Vol: 29, Pages: 514-515, ISSN: 0305-1846
Datla KP, Murray HE, Pillai AV, et al., 2003, Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle, NEUROREPORT, Vol: 14, Pages: 47-50, ISSN: 0959-4965
- Author Web Link
- Cite
- Citations: 60
Murray HE, Pillai AV, McArthur SR, et al., 2003, Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: Differential actions of estrogen in males and females, NEUROSCIENCE, Vol: 116, Pages: 213-222, ISSN: 0306-4522
- Author Web Link
- Cite
- Citations: 140
Graeber MB, Dexter D, Gentleman S, et al., 2002, The UK Multiple Sclerosis Society and UK Parkinson's Disease Society Tissue Banks, Joint Meeting of the Belgian-Dutch-and-German-Societies/47th Annual Meeting of the Deutsche-Gesellschaft-fur-Neuropathologie, Publisher: SPRINGER, Pages: 552-553, ISSN: 0001-6322
Datla K, Christidou MA, Widmer WW, et al., 2002, Citrus flavonoid tangeretin protects against dopaminergic neuronal loss in a rat model of Parkinson's Disease., ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, Vol: 224, Pages: U63-U63, ISSN: 0065-7727
Datla KP, Christidou MA, Widmer WW, et al., 2002, Citrus flavonoid tangeretin accumulates in the brain and pre-treatment protects against dopaminergic neuronal loss in a rat model of Parkinson's disease, BRITISH JOURNAL OF PHARMACOLOGY, Vol: 135, ISSN: 0007-1188
- Author Web Link
- Cite
- Citations: 1
Murray HE, McArthur SR, Dexter DT, et al., 2002, Sex difference in the effects of 6-hydroxydopamine lesions in the nigrostriatal dopaminergic pathway of adult rats and sexually dimorphic actions of 17 β-estradiol., BRITISH JOURNAL OF PHARMACOLOGY, Vol: 135, ISSN: 0007-1188
Gillies G, Murray H, Dexter D, 2002, Organizational and activational effects of sex steroid hormones in the brain: Implications for growth, neuroprotection and disease susceptibility, BRITISH JOURNAL OF PHARMACOLOGY, Vol: 135, ISSN: 0007-1188
Datla KP, Christidou M, Widmer WW, et al., 2001, Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease, NEUROREPORT, Vol: 12, Pages: 3871-3875, ISSN: 0959-4965
- Author Web Link
- Cite
- Citations: 161
Datla KP, Blunt SB, Dexter DT, 2001, Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl<sub>3</sub> nigrostriatal lesions, MOVEMENT DISORDERS, Vol: 16, Pages: 424-434, ISSN: 0885-3185
- Author Web Link
- Cite
- Citations: 88
Rooprai HK, Kandanearatchi A, Maidment SL, et al., 2001, Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells <i>in vitro</i>, NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol: 27, Pages: 29-39, ISSN: 0305-1846
- Author Web Link
- Cite
- Citations: 71
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.